HIV Integrase

HIV Integrase

HIV integrase is one of the three key enzymes of the pol gene of HIV. The retrotranscription-produced viral DNA is inserted into the human cell that has been infected by HIV using the HIV integrase enzyme. The development of new therapeutics for the treatment of AIDS is attracted to this particular stage in the virus life cycle because it offers a variety of points for intervention. Both HIV-1 and HIV-2 integrases are part of the HIV family.

DNA integration is carried out by the 32-kDa HIV-1 integrase in a two-step reaction. Two nucleotides are removed from each 3′ end of the viral DNA created by reverse transcription in the first step, known as 3′ processing. The ends of the viral DNA are integrated into the host genome in the following procedure, known as DNA strand transfer, by means of two transesterification reactions. The three structurally and functionally separate domains that make up integrase are necessary for each stage of the integration reaction.

HIV Integrase related products

Structure Cat No. Product Name CAS No. Product Description
V53377 BDM-2 1643876-33-8 BDM-2 is an IN-LEDGF allosteric inhibitor (INLAI) of HIV-1 integrase (IN) (IC50=47 nM) and has potent antiretroviral (ARV) activity.
V79650 Dihydrobionin B Dihydroobionin B is a potent HIV-1 Integrase inhibitor.
V72003 GSK3839919A 2081127-77-5 GSK3839919A is a potent HIV-1 integrase inhibitor.
V72005 HIV-1 integrase inhibitor 8 1568-80-5 HIV-1 integrase inhibitor 8 is an HIV-1 integrase (HIV-1 integrase) inhibitor, compound 8.
V4329 Raltegravir potassium (MK-0518) 871038-72-1 Raltegravir potassium (formerly also known as MK-0518 potassium; trade name: Isentress) is a novel, potent integrase (IN) inhibitor for WT and S217Q PFV IN with IC50 of 90 nM and 40 nM in cell-free assays, respectively.
V72004 XZ426 1638504-52-5 XZ426 is a potent integrase strand transfer inhibitor (antagonist) with anti-HIV (Human Immunodeficiency Virus) activity.
Contact Us Back to top